Molecular mechanism of c‐Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma

Patients with relapsed/refractory Burkitt's lymphoma (BL) have a dismal prognosis. Current research efforts aim to increase cure rates by identifying high‐risk patients in need of more intensive or novel therapy. The 8q24 chromosomal translocation of the c‐Myc gene, a main molecular marker of B...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ting, Song, Lili, Zhang, Yingwen, Han, Yali, Zhan, Zhiyan, Xv, Zhou, Li, Yang, Tang, Yuejia, Yang, Yi, Wang, Siqi, Li, Shanshan, Zheng, Liang, Li, Yanxin, Gao, Yijin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299692/
https://www.ncbi.nlm.nih.gov/pubmed/32391636
http://dx.doi.org/10.1111/jcmm.15322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299692/
https://www.ncbi.nlm.nih.gov/pubmed/32391636
http://dx.doi.org/10.1111/jcmm.15322

Ejemplares similares